• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.15
  • N225
  • $39,451.06
  • 2.11 %
  • $815.51
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.35
Alterity Therapeutics Limited (ATHE) Earning

Alterity Therapeutics Limited (ATHE) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$1.41

$0.03

(2.17%)

Day's range
$1.4
Day's range
$1.43

Alterity Therapeutics Limited Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 0 $0.00 $0.00 $0.00

Alterity Therapeutics Limited Earnings Date And Information

Alterity Therapeutics Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 812,117 for the quarter and had revenue of 2.61 M for the year. Alterity Therapeutics Limited has generated $0 earnings per share over the last year ($-0.0057 diluted earnings per share) and currently has a price-to-earnings ratio of 0. Alterity Therapeutics Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.

Alterity Therapeutics Limited Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
12/31/2022 Q2 2023 -$0.00 $812,117
08/31/2022 Q1 2023 -$0.00 $762,980
08/31/2022 Q4 2022 -$0.00 $954,269
08/31/2022 Q3 2022 -$0.00 $1.03 M
12/31/2021 Q2 2022 -$0.00 $857,079
09/03/2021 Q1 2022 -$0.00 $852,434
09/02/2021 Q4 2021 -$0.00 $920,918
09/02/2021 Q3 2021 -$0.00 $932,880
12/31/2020 Q2 2021 -$0.00 $726,030
08/31/2020 Q1 2021 -$0.00 $674,157
09/15/2020 Q4 2020 -$0.00 $-640,155
02/27/2020 Q3 2020 -$0.00 $-570,436
02/27/2020 Q2 2020 -$0.00 $650,846
08/30/2019 Q1 2020 -$0.00 $626,070
08/30/2019 Q4 2019 -$0.00 $886,214
02/28/2019 Q3 2019 -$0.00 $896,283
02/28/2019 Q2 2019 -$0.00 $854,588
09/30/2018 Q1 2019 -$0.00 $876,885
08/31/2018 Q4 2018 -$0.00 $610,010
08/31/2018 Q3 2018 -$0.00 $633,160
 

Alterity Therapeutics Limited Earnings: Frequently Asked Questions

  • When is Alterity Therapeutics Limited's earnings date?

    Alterity Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates.

  • How can I listen to Alterity Therapeutics Limited's earnings conference call?

    The conference call for Alterity Therapeutics Limited's latest earnings report can be listened to online.

  • How can I read Alterity Therapeutics Limited's conference call transcript?

    The conference call transcript for Alterity Therapeutics Limited's latest earnings report can be read online.

  • How much revenue does Alterity Therapeutics Limited generate each year?

    Alterity Therapeutics Limited (:ATHE) has a recorded annual revenue of $2.61 M.

  • How much profit does Alterity Therapeutics Limited generate each year?

    Alterity Therapeutics Limited (:ATHE) has a recorded net income of $2.61 M. Alterity Therapeutics Limited has generated $-0.0057 earnings per share over the last four quarters.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.